Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrossword Cybersecurity Regulatory News (CCS)

  • This share is currently suspended. It was suspended at a price of 1.75
  • There is currently no data for CCS

Replacement - Response to Offer

28 Sep 2011 10:37

RNS Number : 0921P
Clarity Commerce Solutions PLC
28 September 2011
 



 

This announcement corrects an incomplete ISIN number contained within the announcement made by the Company at 7.00am on 28 September 2011 under RNS Number 0577P. The announcement stated that the ISIN number is GB0009274. The announcement should state that the ISIN number is GB0009274449. The full corrected announcement follows:

 

Not for release, publication or distribution, in whole or in part, in or into or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction

 

 

 

Clarity Commerce Solutions plc

 

("Clarity", the "Company", or the "Group")

 

 

Response to Offer by Enigmatic Investments Limited

 

 

The Board of directors of Clarity Commerce Solutions plc (AIM:CCS), and their financial advisers, Arbuthnot Securities Limited ("Arbuthnot"), note the offer announced yesterday by Enigmatic Investments Limited for the entire issued and to be issued share capital of the Company.

 

A further announcement will be made shortly, but in the meantime, shareholders are advised to take no action in respect of the offer.

 

 

Rule 2.10

 

In accordance with Rule 2.10 of the City Code on Takeovers and Mergers, Clarity Commerce Solutions plc confirms that it has in issue, 41,427,314 ordinary shares of 25 pence nominal value each under ISIN code GB0009274449.

 

 

 

Enquiries:

 

Clarity Commerce Solutions plc

Stephen Sadler, CFO

 

T: 01256 365 150

Arbuthnot Securities

Antonio Bossi / Paul Gillam / Jonathan Haines

 

T: 020 7012 2000

Biddicks

Sophie McNulty / Zoe Biddick

 

T: 020 3178 6378

 

 

 

Further information

 

Arbuthnot, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for Clarity and no one else in connection with the offer and other matters referred to in this announcement and will not be responsible to any person other than Clarity for providing the protections afforded to clients of Arbuthnot nor for giving advice in relation to the offer or any other matter or arrangement referred to in this announcement.

 

This announcement is not intended to and does not constitute, or form any part of, an offer to sell or an invitation to subscribe for or purchase any securities or the solicitation of an offer to purchase or subscribe for any securities, or the solicitation of any vote or approval in any jurisdiction pursuant to the offer or otherwise. The offer will be made solely through the offer document, which will contain the full terms and conditions of the offer.

 

 

Overseas Shareholders

 

This announcement has been prepared for the purpose of complying with English law and the Code and the information disclosed is not the same as would have been disclosed if this announcement had been prepared in accordance with the laws of jurisdictions outside the UK.

 

The release, distribution or publication of this announcement in jurisdictions other than the UK may be restricted by law and therefore any persons who are subject to the laws of any jurisdiction other than the UK should inform themselves about and observe any applicable requirements.

 

 

Dealing disclosure requirements of the Code

 

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of any class of relevant securities of an offeree company or of any paper offeror (being any offeror other than an offeror in respect of which it has been announced that its offer is, or is likely to be, solely in cash) must make an Opening Position Disclosure following the commencement of the offer period and, if later, following the announcement in which any paper offeror is first identified. An Opening Position Disclosure must contain details of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any paper offeror(s). An Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be made by no later than 3.30 pm (London time) on the 10th business day following the commencement of the offer period and, if appropriate, by no later than 3.30 pm (London time) on the 10th business day following the announcement in which any paper offeror is first identified. Relevant persons who deal in the relevant securities of the offeree company or of a paper offeror prior to the deadline for making an Opening Position Disclosure must instead make a Dealing Disclosure.

 

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1% or more of any class of relevant securities of the offeree company or of any paper offeror must make a Dealing Disclosure if the person deals in any relevant securities of the offeree company or of any paper offeror. A Dealing Disclosure must contain details of the dealing concerned and of the person's interests and short positions in, and rights to subscribe for, any relevant securities of each of (i) the offeree company and (ii) any paper offeror, save to the extent that these details have previously been disclosed under Rule 8. A Dealing Disclosure by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (London time) on the business day following the date of the relevant dealing.

 

If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire or control an interest in relevant securities of an offeree company or a paper offeror, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Opening Position Disclosures must also be made by the offeree company and by any offeror and Dealing Disclosures must also be made by the offeree company, by any offeror and by any persons acting in concert with any of them (see Rules 8.1, 8.2 and 8.4).

 

Details of the offeree and offeror companies in respect of whose relevant securities Opening Position Disclosures and Dealing Disclosures must be made can be found in the Disclosure Table on the Takeover Panel's website at www.thetakeoverpanel.org.uk, including details of the number of relevant securities in issue, when the offer period commenced and when any offeror was first identified. If you are in any doubt as to whether you are required to make an Opening Position Disclosure or a Dealing Disclosure, you should contact the Panel's Market Surveillance Unit on +44 (0)20 7638 0129.

 

 

Publication on website

 

A copy of this announcement will be made available free of charge, subject to certain restrictions

relating to persons resident in any Restricted Jurisdiction, on Clarity's website at www.claritycommerce.com by no later than 12.00 noon (London time) on 29 September 2011.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RSPFMGZLLRFGMZG
Date   Source Headline
14th Dec 20217:00 amRNSNew Customer National Nuclear Laboratory
18th Nov 20217:00 amRNSAppointment of Danone S.A. CISO to Advisory Board
11th Nov 20218:00 amRNSLong Term Incentive Plan Approval and Awards
9th Nov 20217:00 amRNSDarkbeam Collaboration
2nd Nov 20217:00 amRNSInvestor Presentation Webinar
26th Oct 20214:41 pmRNSSecond Price Monitoring Extn
26th Oct 20214:35 pmRNSPrice Monitoring Extension
28th Sep 20217:00 amRNSNotice of Investor Presentation
27th Sep 20217:00 amRNSHalf-year Report
15th Sep 20217:00 amRNSAppointment of URENCO CISO to Advisory Board
31st Aug 202112:00 pmRNSTotal Voting Rights
18th Aug 20217:00 amRNSExercise of Options and Total Voting Rights
16th Aug 20217:00 amRNSHolding(s) in Company
10th Aug 20213:00 pmRNSGrant of Options to Director and Others
9th Aug 20217:00 amRNSAcquisition of Stega. Total Voting Rights
4th Aug 20215:23 pmRNSHolding(s) in Company
4th Aug 20213:33 pmRNSHolding(s) in Company
4th Aug 20218:02 amRNSHolding(s) in Company
30th Jul 20217:00 amRNSTotal Voting Rights
28th Jul 202111:05 amRNSSecond Price Monitoring Extn
28th Jul 202111:00 amRNSPrice Monitoring Extension
28th Jul 20217:00 amRNS£5m Fundraising, Acquisition, Total Voting Rights
29th Jun 20217:00 amRNSSpotlight Sports Group implements Rizikon Pro
28th May 20214:41 pmRNSSecond Price Monitoring Extn
28th May 20214:35 pmRNSPrice Monitoring Extension
28th May 202112:00 pmRNSTotal Voting Rights
26th May 20215:33 pmRNSCorrection - Acquisition of VCL. TVR
26th May 20217:00 amRNSAcquisition of Verifiable Credentials Limited. TVR
25th May 20213:26 pmRNSAGM Result. Board Changes. Share sub-division. TVR
20th May 20217:00 amRNSNotice of Investor Presentation
18th May 20217:00 amRNSMOU with Al-Rawahy Holdings of Sultanate of Oman
10th May 20217:00 amRNSHolding(s) in Company
27th Apr 20217:00 amRNS2020 Annual Results; AGM Notice; Board Changes
16th Mar 20217:00 amRNSCrossword Consulting Helps Vital Signs Solutions
4th Mar 20214:37 pmRNSIASME to deliver CFF Certification using Rizikon
4th Mar 20217:00 amRNSIASME to deliver CFF Certification using Rizikon
1st Mar 202112:26 pmRNSCrossword CEO Tom Ilube CBE appointed Chair of RFU
23rd Feb 20217:00 amRNSUniversity of Glasgow Collaboration
15th Feb 20216:01 pmRNSHolding(s) in Company
12th Feb 20214:45 pmRNSHolding(s) in Company
10th Feb 20211:56 pmRNSHolding(s) in Company
10th Feb 20217:00 amRNS£1.6m Fundraising
27th Jan 20217:00 amRNSRizikon Assurance Promotion to CIISec Members
19th Jan 20217:00 amRNSTrading Update
6th Jan 20215:28 pmRNSReplacement - Webinar Panel Discussion
6th Jan 20217:00 amRNSWebinar Panel Discussion on Cyber Skills Shortage
15th Dec 20207:00 amRNSCrossword wins Innovate UK Grant
11th Dec 20207:00 amRNSSupporting Sultan Qaboos University competition
25th Nov 20207:00 amRNSRizikon Assurance selected by IASME Consortium
10th Nov 202011:07 amRNSCrossword to work on Covid-19 Certificates Trial

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.